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ABSTRACT 
 
Aims: To isolate and evaluate spore-former bacteria for being used as probiotic additives in animal 
nutrition by their technological features. 
Study Design: The study was experimental, by using calves’ faeces for spore-forming identification 
and further evaluation of their “in vitro” probiotic-related properties. 
Place and Duration of Study: Laboratory of Preventive Microbiology, Centro de Referencia para 
Lactobacilos (CERELA-CONICET), between June 2013 and November 2013.  
Methodology: In this work, some Bacillus strains were isolated from calves’ faeces and evaluated 
for their “in vitro” beneficial characteristics: Surface properties, biosurfactant and emulsification 
production, and inhibition of pathogens. The antibiotic sensibility was also assayed. 
Short Research Article 
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Results: Two Bacillus strains were selected, identified by phenotypic and molecular techniques as 
Bacillus subtilis strains M14 and M12. Spores resulted to be more hydrophobic than vegetative cells. 
The M14 strain showed biosurfactant and emulsifying properties. Inhibition assays against 
pathogenic bacteria indicated they inhibit gram-positive microorganisms. The antibiotic susceptibility 
showed that the two strains were sensitive to the antibiotics assayed, except Bacillus M12 that was 
resistant to Kanamycin. 
Conclusion: The results indicate these strains can be further studied for their inclusion in the 
design of a probiotic product for newborn calves. 
 
 
Keywords: Calves; Bacillus-probiotics; prevention; beneficial properties. 
 
1. INTRODUCTION  
 
Probiotic additives in beef and dairy farms are 
alternative adjuncts to be used for animal-feed to 
replace antibiotics -as promoting growth factors 
for animals- mainly in newborn animals [1]. Most 
of the probiotics, defined as “live microorganisms 
administered to the host to produce a beneficial 
physiological effect” [2] applied to farm animals 
are formulated with Lactic Acid Bacteria (LAB) 
[3]. However, some Bacillus species are 
considered as a promising alternative for their 
incorporation in animal-feed [4]. Bacillus species 
have shown to be effective in helping to a 
favorable balance of the microbiota of the 
Gastrointestinal Tract (GIT) and a further 
improvement of the animal performance [5].  
 
One of the main disadvantages of LAB probiotic 
products is their short shelf-life and the low 
resistance to the production process, in contrast 
to the spore former bacteria that are stable and 
resistant. According to the scientific reports of 
the European Food Safety Authority Journal 
(EFSA) to assess the safety of Bacillus [6], the 
strains must be included into the Qualified 
Presumption of Safety (QPS) category. Even 
though certain species of the Bacillus genera as 
B. subtilis group could be potentially included, 
the absence of some toxigenic activity must be 
verified.  
 
As there is not a wide consensus on the more 
adequate beneficial characteristics of the spore-
former bacteria to be included in a probiotic 
formula, and supported by our previous 
experience, our research group has applied 
some “in vitro” assays formerly used for LAB to 
perform the screening and selection of those 
spore-former strains that could be later used for 
the design of a probiotic additive for calves [7-9]. 
Then, the objective of this work was to isolate 
spore-former bacteria from calves, based on the 
host specificity that supports the selection of 
probiotic microorganisms [10]. Also, to evaluate 
the beneficial and safety properties of bacteria 
considered QPS, including the antibiotic 
resistance profile, by employing “in vitro” assays 
related to the capability of the bacteria to adhere 
to the intestinal epithelium [11] or the production 
of antagonistic substances against pathogenic 
bacteria.  
 
2. MATERIALS AND METHODS  
 
2.1 Isolation and Storage of the Spore-
former Bacteria from Calves’ Faeces  
 
The samples were obtained from rectum of 
healthy young calves 0-4 months age, collected 
with sterile swabs in LAPT (1% yeast extract, 
1.5% peptone, 1% tryptone, 1% glucose, 0.1% 
Tween 80) broth [12] supplemented with 0.7% 
agar (wt/vol) as transport medium and stored at 
4ºC until processed. For spore isolation, the 
cultures were heated for 15 min at 85ºC and 
maintained for 3 h at 37ºC and later spread onto 
Nutrient Agar (NA). Plates were incubated for 24 
h in aerobic conditions at 37ºC. The 
quantification of the spore-forming bacteria was 
not performed, because the main interest was to 
isolate and select those that could be screened 
by their beneficial properties. One to three 
colonies were subcultured and stored in Brain 
Heart Infusion (BHI, Britania, Capital Federal, 
Argentine) containing 20% glycerol at -20ºC.  
 
The study protocol was approved by the 
CERELA-CONICET Bioethics Committee. 
 
2.2 Partial Identification of Bacterial 
Strains  
 
2.2.1 Phenotypic characterization  
 
The phenotypic identification was performed by 
standard tests for Bacillus species described in 
Prokaryotes [13]. Also, green malachite 
(Britania, Capital Federal, Argentine) staining 
technique was applied to check sporulation. 
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2.3 Spore Suspension  
 
The Bacillus spores suspensions were obtained 
from Nutrient Broth (NB, Britania, Capital 
Federal, Argentine) supplemented with 1ppm 
manganese (MnSO4.H2O, Aldrich Inc, St Louis, 
USA) and incubated for 4 days at 32ºC with 
agitation and glass beads (2mm diameter, 8% 
wt/vol). The spores were collected when the 
level of sporulation was higher than 90% 
(observed through direct microscopic counts in 5 
fields), washed twice and re-suspended in saline 
solution to a 0.6-0.7 OD600nm. Later, the spore 
suspension was heated for 2 h at 80ºC and 
stored at 4ºC until use. The number of 
vegetative cells at the beginning of the assay 
and the surviving spores were determined by the 
agar plate technique in Nutrient Agar (NA). The 
sporulation index in 12 hours was calculated as 
the log of spores in the final spore suspension 
divided by the log of viable cells, multiplied by 
100. 
 
2.4 Bacterial Surface Properties 
  
2.4.1 Hydrophobicity and auto-aggregation 
characterization  
 
The hydrophobic nature of the surface of 
vegetative and spore cells was studied by the 
method of microbial adhesion to hydrocarbons 
as described by Ocaña et al. [7]. Auto-
aggregation was assessed according to the 
technique published by Ocaña and Nader 
Macías [14]. Briefly, OD600nm variation of cellular 
and spore suspensions in saline solution was 
monitored for 2 hours.  
 
2.4.2 Screening of exopolysaccharide (EPS)  
 
The production of EPS in the Bacillus isolates 
was determined in 24 h cells grown in 10% 
sucrose medium at 37ºC. The capsular 
polysaccharides were evidenced by the Indian 
ink negative staining technique [15].  
 
2.4.3 Biosurfactant detection and 
emulsifying properties  
 
The biosurfactant production was screened by 
the oil spreading technique, as described by 
Youssef et al. [16]. The emulsification activity 
and the interphase stability were evaluated by 
using the modified method of Cooper and 
Goldenberg [17]. One ml Bacillus cell 
suspension obtained from a 24 h culture in NB 
was added to 1.5 ml of n-hexadecane (Merck, 
Darmstadt, Germany) or Kerosene. The mixture 
was vortexed for 2 min and the emulsion index 
obtained after 24 h by the size of the emulsion 
layer divided by the size of the complete 
suspension, multiplied by 100. 
 
2.5 Screening of Antagonistic 
Substances Production  
 
2.5.1 Hydrogen peroxide  
 
The production of H2O2 was qualitatively 
determined by the technique described by 
Juárez Tomás et al. [18]. The isolates were 
inoculated in the TMB-Nutrient Agar (1%) plates 
and incubated for 24 h at 37ºC.  
 
2.5.2 Quantification of organic acids  
 
The organic acids production was quantified in 
the supernatants from the microorganisms 
grown in NB for 12 h with agitation at 37ºC, by 
using HPLC with a column for organic acids 
(HPX-87H 300 x 7.8 mm, BioRad Laboratories, 
Hercules, USA) at 41ºC 11 [9], the detection was 
carried out with an RI detector Knauer K-2301 
(Knauer, Berlin, Germany). 
 
2.5.3 Inhibition of pathogenic bacteria  
 
The production of inhibitory substances was 
evaluated by the plate diffusion technique in the 
supernatant of the selected isolates [19]. 
Aliquots (35 µl) of cell-free supernatant 
centrifuged for 15 min 9,300xg and sterilized by 
filtration from the second subculture of Bacillus 
grown in NB with agitation at 32ºC were placed 
into holes performed in plates containing the 
pathogens in 0.75% agar NA. The plates were 
incubated 48 h at 37°C. An inhibition zone of at 
least 6mm diameter was considered positive. 
The microorganisms used for the detection of 
antagonistic substances were Salmonella Dublin 
MP/07, S. infantis 1533/00, S. thyphimurium 
MP/08, S. enteritidis MP/08, Yersinia 
enterocolitica 1845/00, Escherichia coli 3511AD, 
Streptococcus uberis MP/06, Klebsiella sp. 
MP/05, Staphylococcus aureus MP/08, S. 
epidermidis 3267, Listeria sp. MP/08, Bacillus 
cereus M8. Pathogens were provided by the 
Instituto de Microbiología of UNT (Tucumán, 
Argentine); INTA Rafaela (Santa Fé, Argentine); 
ANLIS (Buenos Aires, Argentine); and isolated in 
our own laboratory. 
 
2.6 Compatibility between Strains  
 
The assays to evaluate the compatibility 
between the selected strains were performed by 
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using the plate diffusion technique [20]. Aliquots 
(35 µl) of cell-free sterile supernatant (12 h 
incubation centrifuged for 15 min at 9,300xg) of 
the strains grown in NB with agitation at 32ºC 
was placed into holes of NA supplemented-
0.75% agar plates containing the Bacillus strains 
as indicator (5x107 CFU ml-1). The plates were 
incubated for 24-48 h and the presence of 
inhibitory halos was considered as positive.  
 
2.7 Evaluation of the Potential Virulence 
Factors  
 
2.7.1 Antibiotic susceptibility  
 
Antibiotic susceptibility and Minimum Inhibitory 
Concentration (MIC) were determined by using 
the disc diffusion method according to CLSI 
recommendations [20,21]. MIC values were 
obtained by the serial antibiotic dilution in 
Mueller Hilton broth (MH, Britania, Capital 
Federal, Argentine). MIC breakpoints and 
interpretations of the antimicrobial susceptibility 
were performed according to EFSA reports [22] 
and Hong et al. [23]. 
 
2.7.2 Haemolytic activity and lecithinase 
production  
 
Hemolytic activity of the strains in BHI sheep-
blood agar (5%) was evaluated. Lecithinase 
activity was determined in Cereus Selective Agar 
(CSA, Merck, Darmstadt, Germany) added with 
egg yolk emulsion (Britania, Capital Federal, 
Argentine). Plates were incubated for 24 h in 
aerobic conditions at 37ºC to detect the 
production of hemolysis and lecithinase [24].  
 
2.8 Genetic Identification of the Strains  
 
The genetic identification of the two strains was 
performed by 16S ribosomal RNA gene 
sequencing. Amplifications of DNA were carried 
out by colony PCR. Strains were cultured in NA; 
three colonies were selected and heated for 3 
min at 85ºC, primers were used for PCR 
amplifications [25]. The amplified products were 
electrophoresed in 0.8% agarose gels and DNA 
sequencing service was performed by Ruralex-
Fagos (Capital Federal, Argentine). The 
identification was obtained from the Genbank-
database by using The Basic Local Alignment 
Search Tool (BLAST) algorithm.  
 
3. RESULTS AND DISCUSSION 
 
Different Bacillus strains were isolated from the 
GIT of newborn calves, the same homologous 
host where the product would be applied, based 
on the host-specificity of the indigenous 
microbiota [10]. Nine spore-former bacterial 
strains were isolated (n=9) and their partial 
phenotypic characterization was performed. 
Based on the macroscopic characteristics of the 
colonies on agar plates, they were stored for 
further identification. Although Bacillus strains 
are frequently isolated from soil, some authors 
suggest that this genus is a natural habitat of the 
intestine with a close relationship with animals 
[26]. All the isolates were spore-former 
microorganisms, but only two strains were 
identified as B. subtilis M12 and B. subtilis M14 
by phenotypic and genotypic assays and          
were used to later study their beneficial 
characteristics. The other spore-forming isolates 
were phenotypically identified as B. cereus and 
related bacteria, and were not included in the 
screening, because these are species that not 
qualify in the QPS category [22] for their 
incorporation to a probiotic additive. 
 
The use of bacterial spores for animal feed has 
shown resistance to the technological processes 
and an easier storage [27]. As the spore 
germination of bacilli was evidenced in the small 
intestine [28], the evaluation of the beneficial 
characteristics of the vegetative cell and spores 
was performed in this work. The spores of B. 
subtilis M12 (5x107 spores ml-1) and M14 (1x109 
spores ml-1) were collected after the sporulation 
procedure. The index of sporulation for B. 
subtilis M12 and M14 was 79% and 92% 
respectively, showing that the spore-forming 
capability is specific or different for each strain. 
 
The results indicate that the hydrophobicity of 
the spores was higher than those of vegetative 
cells, and similar findings were published by 
others authors [29]. Neither the vegetative cells 
nor the spores showed auto-aggregation.  
 
Emulsifying properties and biosurfactant 
production were detected in the strains in 
contact with hexadecane and kerosene (Table 1; 
Fig. 1), showing stable emulsions and a weak 
production of surfactant. The most common site 
for the isolation of microorganisms that produce 
biosurfactant is the hydrocarbon-contaminated 
sites; nevertheless some authors suggest that 
the application of a screening technique is the 
basis for the detection of those that produce 
biosurfactants [30]. 
 
The biosurfactant production assayed in the 
stationary phase of growth indicated that only           
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B. subtilis M14 produced a weak biosurfactant 
by the oil spreading technique (Table 2). The 
use of biosurfactants is related not only with 
bioremediation and pharmaceutical products, but 
also applied in the medical field as protection 
against pathogens [31]. Some authors [32] relate 
the emulsifying characteristics with the surface 
hydrophobicity and production of biosurfactants 
in Bacillus subtilis. This emulsificant technique 
applied to detect biosurfactants could be 
suggested as an “in vitro” method to evaluate the 
beneficial properties in the Bacillus genus. Also, 
antimicrobial properties should be evaluated 
when looking for surfactant activities, because 
the surfactancts have shown the ability to 
destabilize the biological membranes of 
pathogens by their pore forming capacity [33].  
 
 
 
Fig. 1. Emulsions produced by B. subtilis 
M14 supernatant when added to hexadecane 
 
Referred to the EPS production, the two strains 
showed to produce EPS in solid agar medium 
and a weak formation of capsules in the case of 
B. subtilis M14 by the Indian ink negative stain. 
B. subtilis M14 produced a hard floating biofilm 
when incubated in static and aerobic conditions. 
 
Different inhibitory substances produced by 
Bacillus were reported, most of them against 
gram-positive bacteria. The two B. subtilis 
strains inhibited the growth of all the gram-
positive pathogens assayed (Fig. 2, Table 2). 
Further studies are being performed to 
determine the chemical nature of the inhibitory 
substances, because a bacteriocin-like 
substance, as subtilin or a natural antibiotic 
could be involved [4]. On the other hand, they 
did not inhibit any of the gram-negative 
microorganisms assayed. Lactic acid production 
was not detected by HPLC. The two strains were 
compatible, because they did not inhibit each 
other, and were not able to produce H2O2 in the 
medium assayed, then can be included in the 
design of a probiotic product.  
 
 
 
Fig. 2. Production of antagonistic substances 
by Bacillus subtilis M12 (12) and M 14 (14) by 
using Listeria sp as indicator 
 
Antibiotic susceptibility indicates that the Bacillus 
strains were sensitive to all the antibiotics 
assayed, except B. subtilis M12 that showed 
resistance to Kanamycin, according to EFSA 
breakpoints [22] (Table 3a, b). Other authors 
confirmed the resistance of B. subtilis 2335(105) 
to Kanamycin in a commercial probiotic strain, 
by a gene responsible of the cross resistance to 
Amikacin and Tobramycin [34]. 
 
Table 1. Surface properties, emulsification, biofilm and exopolysaccharides (EPS) production 
in spore-former bacteria 
 
 Hydrophobic 
index (%)a* 
Autoaggregation 
pattern† 
EPS 
production‡ 
Biofilm 
production§ 
Emulsifying 
properties|| 
Vegetative 
cell 
Spore Vegetative 
cell 
Spore Hexa-
decane 
Kero-
sene 
Bacillus subtilis 
M12 
10.5±1 35.0±8 (-) (-) (+) (-) 27.4±8 29.6±5 
Bacillus subtilis 
M14 
6.2±3 38.5±15 (-) (-) (+) (+) 9.8±3 25.7±1 
*The autoaggregation pattern, EPS and biofilm production was classified as: (–) negative or (+) positive. 
*The hydrophobic index was determined as described by Ocaña et al.[7] 
†The autoaggregation was performed according to Ocaña and Nader-Macías [14] 
‡EPS production was assayed by the method of Mozzi et al. [15]. 
§Macroscopic observation of the floating biofilms after incubation in nutritive agar. 
||Emulsification index was determined by the method described by Cooper and Goldenberg [17] 
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Table 2. Inhibitory substances produced by spore-former bacteria 
 
 
Inhibitory activity* Lactic 
acid† 
Hydrogen 
peroxide ‡ 
Biosurfactant§ 
Bacillus subtilis 
M12 
Staphylococcus aureus MP/08 S. 
epidermidis 3267 Streptococcus uberis 
MP/06 Listeria sp. MP/08 Bacillus cereus 
M8 
(-) (-) (-) 
Bacillus subtilis 
M14 
Staphylococcus aureus MP/08 S. 
epidermidis 3267 
Streptococcus uberis MP/06 Listeria sp. 
MP/08 Bacillus cereus M8 
(-) (-) (+) 
*Analyzed by the plate diffusion method. 
†The lactic acid production was quantified by HPLC. 
‡The production of H2O2 in TMB-plates was performed according to Juárez-Tomás et al. [18]. 
§ Biosurfactant detection was determined by the method described by Youssef et al. [16] 
 
Table 3a. Antibiotic susceptibility of the spore-former strains 
 
Antibiotic disc* Bacillus subtilis M12 Bacillus subtilis M14 
Size of the 
inhibitory halo 
(mm)† 
Interpretation Size of the 
inhibitory halo 
(mm)† 
Interpretation 
Clindamycin (2 µg) 21 S 24 S 
Trimethoprim-
Sulfamethoxazole (25 µg) 
31 S 35 S 
Erythromycin (15 µg) 31 S 27 S 
Ciprofloxacin (5 µg) 30 S 35 S 
Gentamicin (10 µg) 25 S 26 S 
*Analyzed by the plate diffusion method. The interpretation of the results was performed according to the 
breakpoints suggested by Hong et al. [23]. 
*The concentration of the antibiotic in the discs (6 mm) is shown in brackets. 
†Diameter of inhibition from two individual experiments. S: sensitive, R: resistant 
 
Table 3b. Antibiotic susceptibility of the spore-former strains. Determination of the minimum 
inhibitory concentration (MIC) 
 
Antibiotic MIC (µg/ml) Breakpoints* 
Bacillus subtilis M12 Bacillus subtilis M14 
Chloramphenicol 16 16 ≥8 
Tetracycline 4 4 ≥8 
Oxytetracycline 4 8 ND 
Kanamycin 64 <0.25 ≥8 
Erythromycin 2 0.5 ≥4 
ND: not determined 
*Bacillus ESFA breakpoints 
 
The safety assays (lecithinase and hemolysis 
tests) indicate that the two strains do not have 
cytotoxic phospholipases or produce a weak 
alpha-hemolysis in sheep blood, and did not 
showed lecithinase activity. Animal studies have 
shown that B. cereus IP 5832, a hemolytic strain, 
produced acute toxicity by the intra-peritoneal 
administration in mice, in contrast with B. subtilis 
3 and B. licheniformis 31 with no hemolytic 
properties [23].  
4. CONCLUSION 
 
The results obtained in this paper show that 
some techniques applied to determine the 
beneficial properties of Lactic Acid bacteria could 
be used for the screening of this type of 
characteristics in spore-forming bacteria. The 
two Bacillus strains selected are being evaluated 
to define their inclusion in a product for calves. 
The results obtained support their use as 
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probiotic according to the EFSA 
recommendations, and they could be combined 
with the LAB previously selected for their 
beneficial properties [9], to restore the intestinal 
microbioma of calves as multi-strains-host-
specific probiotic.  
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